تقرير
أعرض في EDS

Quantitative MR Imaging in Locally Advanced Cervical Cancer (IQ-EMBRACE)

التفاصيل البيبلوغرافية
العنوان: Quantitative MR Imaging in Locally Advanced Cervical Cancer (IQ-EMBRACE)
المؤلفون: The Netherlands Cancer Institute
المساهمون: Jesper Kallehauge, Medical Physicist
المصدر: Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM, Grecula JC, Sammet S, Sammet CL, J G, Zhang J, Knopp MV, Yuh WT. Characterg tumor heterogeney wh functnal agg and quantyg hh-rk tumor volume for early predtn of treatment outcome: cerval cancer as a model. t J Radt Oncol Bl Phys. 2012 Jul 1;83(3):972-9. do 10.1016/j.robp.2011.08.011. Epub 2011 Dec 28.
Mayr NA, Wang JZ, Zhang D, Grecula JC, Lo SS, Jaroura D, Montebello J, Zhang H, LK, Lu L, Huang Z, Fowler JM, Wu DH, Knopp MV, Yuh WT. Longudal changes tumor perfusn pattern durg the radtn therapy course and s clal pact cerval cancer. t J Radt Oncol Bl Phys. 2010 Jun 1;77(2):502-8. do 10.1016/j.robp.2009.04.084. Epub 2009 Sep 21.
Andersen EK, Hole KH, Lund KV, Sundfor K, Krtensen GB, Lyng H, Malen E. Dynam contrast-enhanced MRof cerval cancers: temporal percente screeng of contrast enhancement ents parameters for predtn of chemoradrestance. t J Radt Oncol Bl Phys. 2012 Mar 1;82(3):e485-92. do 10.1016/j.robp.2011.05.050. Epub 2011 Oct 17.
Loncaster JA, Carrgton BM, Sykes JR, Jones AP, Todd SM, Cooper R, Buckley DL, Davson SE, Logue JP, Hunter RD, West CM. Predtn of radtherapy outcome usg dynam contrast enhanced MRof carcoma of the cerv. t J Radt Oncol Bl Phys. 2002 Nov 1;54(3):759-67. do 10.1016/s0360-3016(02)02972-3.
Takayama Y, Ohno T, Khoto R, Kato S, Yoneyama R, Kandatsu S, Tsuj H, Obata T. Predtn of early response to radtherapy of utere carcoma wh dynam contrast-enhanced MR agg usg pel analys of MR perfusn agg. Magn Reson agg. 2009 Apr;27(3):370-6. do 10.1016/j.mr2008.07.007. Epub 2008 Sep 2.
Semple S Harry VN, Park DE, Gbert FJ. A combed pharmacoket and radlog assessment of dynam contrast-enhanced magnet resonance agg predts response to chemoradtn locally advanced cerval cancer. t J Radt Oncol Bl Phys. 2009 Oct 1;75(2):611-7. do 10.1016/j.robp.2009.04.069.
Mayr NA, Yuh WT, Zheng J, Ehrhardt JC, Magnotta VA, Sorosky J Pelsang RE, Oberley LW, Hussey DH. Predtn of tumor control patnts wh cerval cancer: analys of combed volume and dynam enhancement pattern by MR agg. AJR Am J Roentgenol. 1998 Jan;170(1):177-82. do 10.2214/ajr.170.1.9423627.
Mayr NA, Yuh WT, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky J Dav CS, Wen BC, Mart DD, Pelsang RE, Buller RE, Oberley LW, Mellenberg DE, Hussey DH. Tumor perfusn studs usg fast magnet resonance agg technue advanced cerval cancer: a new nonvase predte assay. t J Radt Oncol Bl Phys. 1996 Oct 1;36(3):623-33. do 10.1016/s0360-3016(97)85090-0.
Mayr NA, Yuh WT, Arnholt JC, Ehrhardt JC, Sorosky J Magnotta VA, Berbaum KS, Zhen W, Paulo AC, Oberley LW, Sood AK, BuattJM. Pel analys of MR perfusn agg predtg radtn therapy outcome cerval cancer. J Magn Reson agg. 2000 Dec;12(6):1027-33. do 10.1002/1522-2586(200012)12:63.0.co;2-5.
MannellL, Patterson AJ, Zahra M, Prst AN, Graves MJ, Lomas DJ, Tan LT, Crawford R, Brenton J, Sala E. Evaluatn of nonenhancg tumor fractn assessed by dynam contrast-enhanced MRsubtractn as a predtor of decrease tumor volume response to chemoradtherapy advanced cerval cancer. AJR Am J Roentgenol. 2010 Aug;195(2):524-7. do 10.2214/AJR.09.3437.
Zahra MA, Tan LT, Prst AN, Graves MJ, Arends M, Crawford RA, Brenton JD, Lomas DJ, Sala E. Semuantate and quantate dynam contrast-enhanced magnet resonance agg measurements predt radtn response cerv cancer. t J Radt Oncol Bl Phys. 2009 Jul 1;74(3):766-73. do 10.1016/j.robp.2008.08.023. Epub 2008 Nov 18.
Gong QY, Brunt JN, Romank CS, Oakley JP, Tan LT, Roberts N, Whehouse GH, Jones B. Contrast enhanced dynam MRof cerval carcoma durg radtherapy: early predtn of tumour regressn rate. Br J Radl. 1999 Dec;72(864):1177-84. do 10.1259/bjr.72.864.10703475.
Andersen EK, Krtensen GB, Lyng H, Malen E. Pharmacoket analys and k-means clusterg of DCEMR ages for radtherapy outcome predtn of advanced cerval cancers. Acta Oncol. 2011 Aug;50(6):859-65. do 10.3109/0284186X.2011.578586.
Mayr NA, Wang JZ, Zhang D, Montebello JF, Grecula JC, Lo SS, Fowler JM, Yuh WT. Synergt effects of hemoglob and tumor perfusn on tumor control and surval cerval cancer. t J Radt Oncol Bl Phys. 2009 Aug 1;74(5):1513-21. do 10.1016/j.robp.2008.09.050. Epub 2009 Mar 13.
Huang Z, Yuh KA, Lo SS, Grecula JC, Sammet S, Sammet CL, J G, Knopp MV, Wu Q, Beauchamp NJ 3rd, Yuh WT, Wang R, Mayr NA. Valatn of optal DCE-MRperfusn threshold to classy at-rk tumor agg voxels heterogeneous cerval cancer for outcome predtn. Magn Reson agg. 2014 Dec;32(10):1198-205. do 10.1016/j.mr2014.08.039. Epub 2014 Aug 29.
Torhe T, Malen E, Kvaal K, Lyng H, dahl UG, Andersen EK, Futsaether CM. Classatn of dynam contrast enhanced MR ages of cerval cancers usg texture analys and support vector maches. EE Trans Med agg. 2014 Aug;33(8):1648-56. do 10.1109/TM2014.2321024. Epub 2014 Apr 29.
Donaldson SB, Buckley DL, O'Connor JP, Davson SE, Carrgton BM, Jones AP, West CM. Enhancg fractn measured usg dynam contrast-enhanced MRpredts dease-free surval patnts wh carcoma of the cerv. Br J Cancer. 2010 Jan 5;102(1):23-6. do 10.1038/sj.bjc.6605415. Epub 2009 Nov 17.
Mayr NA, Yuh WT, Jajoura D, Wang JZ, Lo SS, Montebello JF, Porter K, Zhang D, McMeek DS, BuattJM. Ultra-early predte assay for treatment faure usg functnal magnet resonance agg and clal prognost parameters cerval cancer. Cancer. 2010 Feb 15;116(4):903-12. do 10.1002/cncr.24822.
K JH, K CK, Park BK, Park SY, Huh SJ, K B. Dynam contrast-enhanced 3-T MR agg cerval cancer before and after concurrent chemoradtherapy. Eur Radl. 2012 Nov;22(11):2533-9. do 10.1007/s00330-012-2504-4. Epub 2012 Jun 1.
Boss EA, Massuger LF, Pop LA, Verhoef LC, Human HJ, Boonstra H, Barentsz JO. Post-radtherapy contrast enhancement changes fast dynam MRof cerval carcoma. J Magn Reson agg. 2001 Apr;13(4):600-6. do 10.1002/jmr1084.
Chen YB, Hu CM, Chen GL, Hu D, Lo J. Stagg of utere cerval carcoma: whole-body dfusn-wehted magnet resonance agg. Abdom agg. 2011 Oct;36(5):619-26. do 10.1007/s00261-010-9642-4.
L Y, BaR, Sun H, L H, Wang D. Dfusn-wehted magnet resonance agg of utere cerval cancer. J Comput Asst Tomogr. 2009 Nov-Dec;33(6):858-62. do 10.1097/RCT.0b013e31819e93af.
Naganawa S, Sato C, Kumada H, hakT, Mra S, Takawa O. Apparent dfusn coeffnt cerval cancer of the uterus: comparon wh the normal utere cerv. Eur Radl. 2005 Jan;15(1):71-8. do 10.1007/s00330-004-2529-4. Epub 2004 Nov 5.
Kkesmez O, Bayramoglu S, cE, ClT, Kayhan A. Quantate dfusn-wehted magnet resonance agg of normal and deased utere zones. Acta Radl. 2009 Apr;50(3):340-7. do 10.1080/02841850902735858.
Charles-Edwards EM, Messu C, Morgan VA, De Sva SS, McWhney NA, Katesmark M, Attygalle AD, DeSouza NM. Dfusn-wehted agg cerval cancer wh an endovagal technue: potentl value for provg tumor detectn stage and 1 dease. Radlogy. 2008 Nov;249(2):541-50. do 10.1148/radl.2491072165.
McVeh PZ, Syed AM, Mosev M, Fyles A, Haer MA. Dfusn-wehted MR cerval cancer. Eur Radl. 2008 May;18(5):1058-64. do 10.1007/s00330-007-0843-3. Epub 2008 Jan 12.
Xue HD, LS, Sun F, Sun HY, J ZY, Yang JX, Yu M. Clal applatn of body dfusn wehted MR agg the dgnos and preoperate N stagg of cerval cancer. Ch Med ScJ. 2008 Sep;23(3):133-7. do 10.1016/s1001-9294(09)60027-4.
Hoogendam JP, Klerkx WM, de Kort GA, Bat S, Zweemer RP, S-Go DM, Verheen RH, MalWP, Veldhu WB. The fluence of the b-value combatn on apparent dfusn coeffnt based dferenttn between malnant and benn tsue cerval cancer. J Magn Reson agg. 2010 Aug;32(2):376-82. do 10.1002/jmr22236.
Kundu S, Chopra S, Verma A, Mahantshetty U, Engeer R, Shrastava SK. Functnal magnet resonance agg cerval cancer: current evence and future dectns. J Cancer Res Ther. 2012 Jan-Mar;8(1):11-8. do 10.4103/0973-1482.95167.
Gladwh A, Mosev M, Fyles A, X J, Halankar J, Metser U, Jng H, Becker N, Lev W, Manchul L, Foltz W, Han K. Assoctn of Apparent Dfusn Coeffnt wh Dease Recurrence Patnts wh Locally Advanced Cerval Cancer Treated wh Radal Chemotherapy and Radtn Therapy. Radlogy. 2016 Apr;279(1):158-66. do 10.1148/radl.2015150400. Epub 2015 Oct 27.
Harry VN, Semple S Gbert FJ, Park DE. Dfusn-wehted magnet resonance agg the early detectn of response to chemoradtn cerval cancer. Gynecol Oncol. 2008 Nov;111(2):213-20. do 10.1016/j.ygyno.2008.07.048. Epub 2008 Sep 6.
Somoye G, Harry V, Semple S, Platant G, Scott N, Gbert FJ, Park D. Early dfusn wehted magnet resonance agg can predt surval women wh locally advanced cancer of the cerv treated wh combed chemo-radtn. Eur Radl. 2012 Nov;22(11):2319-27. do 10.1007/s00330-012-2496-0. Epub 2012 Jun 1.
MarconDG, FregnanJH, RossRR, Netto AK, LucchesFR, Tsunoda AT, Kamrava M. Pre-treatment MRmum apparent dfusn coeffnt value a potentl prognost agg bmarker cerval cancer patnts treated wh defe chemoradtn. BMC Cancer. 2016 Jul 28;16:556. do 10.1186/s12885-016-2619-0.
Quantitative MR Imaging in Locally Advanced Cervical Cancer Sub-study Under the EMBRACE II Protocol
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03210428Test
Other URLs: https://www.embracestudy.dkTest/
قاعدة البيانات: ClinicalTrials.gov
الوصف
الوصف غير متاح.